IDEXX Laboratories (NASDAQ:IDXX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
IDEXX Laboratories beat estimated earnings by 0.44%, reporting an EPS of $2.27 versus an estimate of $2.26.
Revenue was up $58.84 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.18 which was followed by a 0.88% increase in the share price the next day.
Here's a look at IDEXX Laboratories's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 1.71 | 1.91 | 2.04 | 1.71 |
| EPS Actual | 1.89 | 2.03 | 2.34 | 2.35 |
| Revenue Estimate | 784.43M | 798.16M | 782.99M | 737.38M |
| Revenue Actual | 801.09M | 810.42M | 826.14M | 777.71M |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
IDEXX Laboratories management provided guidance for FY 2022, expecting earnings between $8.11 and $8.35 per share.
To track all earnings releases for IDEXX Laboratories visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
